Healthcare's AI investment is accelerating, but the dollars are concentrated in administrative and documentation use cases that will commoditize within eighteen months. The AI deployments producing real clinical and financial returns are the ones that shorten time-to-intervention rather than time-to-bill, including bedside predictive monitoring, continuous remote monitoring, and clinical workflow

Two federal actions in the past week, the launch of CMS's ACCESS Model with 150+ accepted participants and the introduction of the bipartisan Chronic Care Management Improvement Act of 2026, just rewrote the economics of chronic care. ACCESS pays providers for outcomes over a ten-year horizon. The new bill would eliminate the 20 percent patient cost-share that has suppressed CCM enrollment for a d

UnitedHealthcare attempted to strip RPM coverage for chronic hypertension, diabetes, and COPD, limiting it to heart failure and gestational hypertension only. They delayed after industry backlash but still plan to enforce the policy in 2026. The evidence directly contradicts their "no evidence" claim: large studies show RPM reduces blood pressure by 7-17 mmHg and cuts uncontrolled hypertension rat